OPZELURA
Google image searchProduct monograph
Active ingredient
ruxolitinib (ruxolitinib phosphate), 1.5 %/W/W
DIN: 02552434
Dosage form(s): CREAM
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: INCYTE CORPORATION
Date: 28-NOV-2024
ATC:
- D11 — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D11A — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD)
- D11AH — Agents for atopic dermatitis, excluding corticosteroides (ATC, ATC/DDD)
- D11AH09 — RUXOLITINIB (ATC/DDD)
Reference brand drug: Opzelura
